Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Sergey Zhuplatov

Sergey Zhuplatov

Director Medical Alignment at AstraZeneca
University of Utah Medical School
USA

Biography

Dr. Sergey Zhuplatov is a Medical Director of the Metabolic Strategy and Development of AstraZeneca LP. Fort Washington, PA. He was graduated as MD at the Izhevsk State Medical Academy in Russia before finishing his fellowship in Internal Medicine/Endocrinology at Moscow Academy of Post diploma Education and Moscow Medical Institute of Transplantology in 1986. He accepted tenure and leading clinical consultant position in Endocrinology/Cardiology clinic at his Alma Mater ISMA. At this time, he started his Ph.D. dissertation in Cardiology with prevention of progressive CV events in Diabetes Mellitus Patients as the main topic, which was perfectly defended at Ural State Medical Academy on 1991. Dr. Zhuplatov has been working as an Assistant Professor and practicing physician till his emigration to the USA in 2002 as an exceptional ability person visa waiver. Before that he worked 2 years as a Medical Scientific Consultant for Merck S&D Co., and also as a Chief Medical Officer in Private Medical Clinic for 2 years. He published different works in Internal Medicine, Lipidology, Endocrinology, and Cardiology. He continued his scientific work in University of Utah Medical School till his merge to Pharmaceutical Industry in 2008. Since then he is working in Cardio/Metabolic area of Medical Affairs and Clinical Development of Bristol-Meyers Squibb and AstraZeneca Co. He currently resides in Bucks County PA with his wife Irina, Industrial Psychology Ph.D. They both like fine arts, travel, and reading. His two sons are graduate students in Economy and Medicine.

Research Interest

Diabetology,Lipids,Ischemic Heart Disease, Microcirculation,Echocardiography,Obesity.